EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study

Jonathan Brett iD, Claudia Bruno, Bianca Varney, Alys Havard iD, Antonia Shand, Krista F Huybrechts iD, Helga Zoega

International Journal of Epidemiology · 11.06.2025 · 54 (4)

DOI: 10.1093/ije/dyaf137 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Epidemiology, online erschienen am 06.08.2025. Verfasst von Jonathan Brett und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, St Vincent's Clinical School, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Analgesics, Opioid, Abruptio Placentae, Premature Birth, Pre-Eclampsia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Centre of Research Excellence in Medications Intelligence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Analgesic opioid use in pregnancy could increase the risk of disorders related to placental malperfusion, but this relationship is incompletely characterized. We aimed to study the causal association between analgesic opioids in pregnancy and placental abruption, pre-eclampsia, preterm birth, and fetal growth restriction (FGR).

Methods

We conducted a population-based cohort study of pregnancies resulting in birth at ≥20 weeks of gestation between July 2013 and December 2019 in New South Wales, Australia. Linked data on pregnancy, births, medication dispensation, and health services were used. Opioid exposure was defined as at least one opioid dispensation from the last menstrual period to birth. We stratified analyses by exposure in early (≤20 weeks) and/or late (>20 weeks) pregnancy and opioid type by using non-exposed pregnancies as a comparator. We estimated risks by using Cox proportional-hazards models and time-varying exposure, adjusting for demographics, comorbidities, and other medications.

Results

Among 509 971 births, 32 266 (6.3%) had an opioid dispensation. We observed modestly increased risks with any opioid exposure for placental abruption [adjusted hazard ratio (HR) 1.22, 95% confidence interval (CI) 1.06–1.41] and preterm birth (adjusted HR 1.23, 95% CI 1.18–1.28), but not for pre-eclampsia (adjusted HR 1.06, 95% CI 0.99–1.13) or FGR (adjusted HR 0.95, 95% CI 0.88–1.02). Risks of abruption were the most elevated when exposure occurred in both early and late pregnancy (adjusted HR 1.76, 95% CI 1.30–2.40) and for preterm birth when exposure occurred in late-only pregnancy (adjusted HR 1.36, 95% CI 1.27–1.45). Monotherapy with both codeine and oxycodone was associated with elevated risks of abruption and preterm birth.

Conclusion

In this population-based cohort study, we observed modestly increased risks of preterm birth and placental abruption after analgesic opioid use in pregnancy, driven by codeine and oxycodone—the two most frequently used opioids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidAbruptio PlacentaePremature BirthPre-EclampsiaFetal Growth RetardationHumansFemalePregnancyAdultCohort StudiesNew South WalesYoung AdultProportional Hazards ModelsInfant, NewbornPregnancy Complications

Stichwörter der Autor:innen

analgesicischaemic placental diseaseopioidplacental abruptionplacental malperfusionpre-eclampsiapregnancypretermsmall for gestational age

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Faculty of Medicine and Health, St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
  • Faculty of Medicine and Health, School of Population Health, University of New South Wales, Sydney, Australia.
  • National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
  • Maternal and Fetal Medicine, Royal Hospital for Women, Sydney, Australia.
  • Faculty of Medicine and Health, Leeder Centre for Health Policy, Economics, and Data, Child Population and Translational Health Research, The University of Sydney, Sydney, Australia.
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.

ORCID-Profile: Jonathan Brett, Alys Havard, Krista F Huybrechts

Förderung

  • National Health and Medical Research Council
  • Centre of Research Excellence in Medications Intelligence

Zitieren

APA

Brett, J., Bruno, C., Varney, B., Havard, A., Shand, A., Huybrechts, K. F., & Zoega, H. (2025). Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study. International Journal of Epidemiology, 54(4). https://doi.org/10.1093/ije/dyaf137

Vancouver

Brett J, Bruno C, Varney B, Havard A, Shand A, Huybrechts KF, et al. Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study. International Journal of Epidemiology. 2025;54(4). doi:10.1093/ije/dyaf137

BibTeX
@article{Brett2025,
  author = {Brett, Jonathan and Bruno, Claudia and Varney, Bianca and Havard, Alys and Shand, Antonia and Huybrechts, Krista F and Zoega, Helga},
  title = {Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study},
  journal = {International Journal of Epidemiology},
  year = {2025},
  volume = {54},
  number = {4},
  doi = {10.1093/ije/dyaf137}
}
Kostenlos starten →